NCT05842902 Resilience Mobile App for Teens and Young Adults With Cancer
| NCT ID | NCT05842902 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Seattle Children's Hospital |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2023-09-12 |
| Primary Completion | 2027-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2023-09-12 with a primary completion date of 2027-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this pilot trial is to examine whether a mobile app version of the Promoting Resilience in Stress Management (PRISM) intervention is acceptable, easy to use, and helps improve quality of life and mental health symptoms.
Eligibility Criteria
Inclusion Criteria: * Age 12-25 years * Diagnosis of new malignancy within 12 months of enrollment treated with chemotherapy and/or radiation therapy at Seattle Children's Hospital (SCH) * Patient able to speak/read/write English or Spanish language * Cognitively able to participate in mHealth psychosocial intervention and interactive interviews Exclusion Criteria: * Patient refusal to participate (any age), or parental refusal to participate for patients less than 18 years of age * Patients with diagnosis of malignancy \>12 months * Patients with relapsed, recurrent, or refractory disease * Patient without chemotherapy and/or radiation therapy as part of cancer treatment (e.g., surgical resection only patients are not-eligible) * Cognitively or physically unable to participate in mHealth psychosocial intervention and surveys
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05842902 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 25 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05842902 currently recruiting?
Yes, NCT05842902 is actively recruiting participants. Contact the research team at nancy.lau@seattlechildrens.org for enrollment information.
Where is the NCT05842902 trial being conducted?
This trial is being conducted at Seattle, United States.
Who is sponsoring the NCT05842902 clinical trial?
NCT05842902 is sponsored by Seattle Children's Hospital. The trial plans to enroll 80 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.